阻塞性睡眠呼吸暂停综合征在慢性全闭性皮肤通道冠状动脉干预中;来自PROGRESS-CTO注册表的见解
Ozgur Selim Ser1, Deniz Mutlu1, Michaella Alexandrou1
1Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, MN, USA.
概括
患有阻塞性睡眠呼吸暂停综合征 (OSAS) 的患者经历慢性全闭症 (CTO) 皮肤冠状动脉干预 (PCI) 有更复杂的病例,但类似的程序成功. 然而,OSAS患者面临更高的重大心脏不良事件和术后死亡风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 睡眠医学 睡眠医学
背景情况:
- 阻塞性睡眠呼吸暂停综合征 (OSAS) 是一种普遍的疾病,经常与心血管疾病并存.
- 慢性全塞 (CTO) 穿皮冠状动脉干预 (PCI) 是一种复杂的程序,用于治疗具有挑战性的冠状动脉阻塞.
研究的目的:
- 研究诊断为OSAS的患者中CTO PCI的程序结果和长期结果.
- 为了比较CTO PCI在患有和没有OSAS的患者之间的特征和临床结果.
主要方法:
- 一项多中心注册表研究分析了2012年至2024年期间执行的7408个CTO PCI的数据.
- 患者被分为两组:患有OSAS (942名患者) 和没有OSAS的患者.
- 程序的成功,住院并发症和随访结果,包括主要不良心脏事件 (MACE) 和死亡被比较.
主要成果:
- 患有OSAS的患者呈现出更多的并发症和更高的J-CTO和PROGRESS-CTO得分,表明更复杂的CTO.
- 对于CTO PCI的技术和程序成功率在OSAS和非OSAS组之间是相似的 (约为87%).
- 尽管周围手术安全性相似,但OSAS患者的随访MACE (3.9%对1.6%) 和死亡 (2.6%对0.6%) 率显著更高.
结论:
- 阻塞性睡眠呼吸暂停综合征经常在接受CTO PCI的患者中观察到.
- 虽然CTO PCI在OSAS患者的周边过程期间是技术上可行的和安全的,但在随访期间,他们表现出更高的不良事件风险.
- 在CTO PCI之后,OSAS是MACE增加的独立预测器,突出了对综合管理策略的需求.
更多相关视频
相关概念视频
Sleep Apnea
119
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
119
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K


